172,528 Shares in ASP Isotopes Inc. (NASDAQ:ASPI) Acquired by Apis Capital Advisors LLC

Apis Capital Advisors LLC acquired a new position in shares of ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 172,528 shares of the company's stock, valued at approximately $782,000. ASP Isotopes comprises approximately 0.5% of Apis Capital Advisors LLC's portfolio, making the stock its 28th largest holding. Apis Capital Advisors LLC owned about 0.24% of ASP Isotopes at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Hanson & Doremus Investment Management acquired a new stake in ASP Isotopes during the fourth quarter worth approximately $27,000. B. Riley Wealth Advisors Inc. acquired a new position in shares of ASP Isotopes during the 3rd quarter valued at $42,000. Avantax Advisory Services Inc. acquired a new stake in ASP Isotopes in the fourth quarter worth $45,000. Russell Investments Group Ltd. grew its holdings in ASP Isotopes by 56.3% in the fourth quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company's stock worth $46,000 after purchasing an additional 3,682 shares during the period. Finally, SVB Wealth LLC bought a new stake in ASP Isotopes in the fourth quarter valued at $49,000. 16.80% of the stock is currently owned by institutional investors.

Insider Activity at ASP Isotopes

In other news, CEO Paul Elliot Mann sold 316,666 shares of the stock in a transaction dated Thursday, April 17th. The shares were sold at an average price of $5.62, for a total value of $1,779,662.92. Following the sale, the chief executive officer now directly owns 7,315,454 shares of the company's stock, valued at approximately $41,112,851.48. This represents a 4.15 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Robert Ainscow sold 66,668 shares of the company's stock in a transaction dated Thursday, April 17th. The stock was sold at an average price of $5.62, for a total value of $374,674.16. Following the completion of the transaction, the chief operating officer now owns 1,419,992 shares in the company, valued at $7,980,355.04. This represents a 4.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 766,667 shares of company stock valued at $4,358,502 over the last 90 days. Insiders own 21.40% of the company's stock.

ASP Isotopes Stock Up 6.4 %

ASP Isotopes stock traded up $0.35 during mid-day trading on Thursday, reaching $5.85. The stock had a trading volume of 1,118,375 shares, compared to its average volume of 2,366,660. The firm has a market capitalization of $439.11 million, a PE ratio of -9.59 and a beta of 3.40. ASP Isotopes Inc. has a fifty-two week low of $1.86 and a fifty-two week high of $9.33. The stock's 50-day simple moving average is $4.87 and its 200-day simple moving average is $5.38. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.